PCR is a revolutionary method that amplifies DNA exponentially and underpins modern genetic testing and forensics. The procedure cycles through three steps: 1) denaturation at about 95 °C to separate strands, 2) annealing where designed primers bind to the target sequence, and 3) extension in which a heat-stable DNA polymerase synthesizes new strands. Because the primers determine where copying starts, even trace amounts of DNA can be detected with high specificity. Before PCR, cloning or radioactive probes were labor-intensive alternatives. The technique is vital for HIV detection, paternity tests, oncogene analysis, and more. Widespread use of automated thermal cyclers has made PCR accessible to schools, hospitals, and small labs.

Proposed by Mullis in 1983, PCR is an in vitro DNA replication system driven by thermal cycling; its practical adoption soared after the addition of Taq polymerase, a heat-resistant enzyme from Thermus aquaticus. Exponential amplification (2^n after n cycles) means that roughly 30 cycles yield a one-billion-fold increase. Primer design enables point-mutation analysis, quantitative PCR (qPCR), reverse-transcription PCR (RT-PCR) and other variants, making the technique indispensable for gene-expression studies and viral RNA detection. PCR products feed directly into downstream analyses such as electrophoresis, sequencing, and cloning. To improve specificity, hot-start, long, and multiplex PCR protocols were created. Digital PCR now allows absolute quantification, and integration with microfluidics has produced point-of-care testing devices.

PCR combines reversible thermal denaturation of double-stranded DNA with the extension activity of thermostable polymerases, constituting a non-equilibrium reaction system that can be modeled using hybrid Michaelis–Menten kinetics and Arrhenius-governed rate constants. Specificity is compromised by inhibitors, primer-dimers, and secondary structures in GC-rich regions; additives such as DMSO or betaine modulate melting temperature to alleviate these issues. Beyond end-point detection, fluorescent probes (e.g., TaqMan, Scorpion) enable real-time monitoring and Ct-value analysis, while Poisson-based digital PCR achieves single-molecule quantification. Coupling with high-throughput NGS permits amplicon sequencing for microbiome profiling and barcode-mediated sample multiplexing. Emerging platforms like CRISPR-Cas12/13-driven SHERLOCK and DETECTR marry isothermal amplification with collateral cleavage signaling, pushing toward rapid point-of-care infectious-disease diagnostics.